Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice

Cell

Volumn 95, Issue 2, 1998, Pages 163-175

  Hanna, Zaher ^a,b   Kay, Denis G ^a   Rebai, Najet ^a   Guimond, Alain ^a   Jothy, Serge ^c,d   Jolicoeur, Paul ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; NEF PROTEIN; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; TRANSGENIC MOUSE; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0032538278     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81748-1     Document Type: Article

References (36)

1. Brady, H.J., Pennington, D.J., Miles, C.G., and Dzierzak, E.A. (1993). CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J. 12, 4923-4932.
2. Calvelli, T.A., and Rubinstein, A. (1990). Pediatric HIV infection: a review. Immunodefic. Rev. 2, 83-129.
3. Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D., and Baltimore, D. (1998). HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401.
4. Coodley, G.O., Loveless, M.O., and Merrill, T.M. (1994). The HIV wasting syndrome: a review. J. Acquir. Immune Defic. Syndr. 7, 681-694.
5. Deacon, N.J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D.J., McPhee, D.A., Greenway, A.L., Ellett, A., Chatfield, C., and et al. (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
6. Enger, C., Graham, N., Peng, Y., Chmiel, J.S., Kingsley, L.A., Detels, R., and Munoz, A. (1996). Survival from early, intermediate, and late stages of HIV infection. JAMA 275, 1329-1334.
7. Garcia, J.V., and Miller, A.D. (1991). Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511.
8. Gibbs, J.S., Regier, D.A., and Desrosiers, R.C. (1994). Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. Aids Res. Hum. Retroviruses 10, 343-350.
9. Goudreau, G., Carpenter, S., Beaulieu, N., and Jolicoeur, P. (1996). Vacuolar myelopathy in transgenic mice expressing human immunodefiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter. Nat. Med. 2, 655-661.
10. Greenway, A., Azad, A., Mills, J., and McPhee, D. (1996). Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70, 6701-6708.
11. +T cells, and in macrophage of transgenic mice. Mol. Cell. Biol. 14, 1084-1094.
12. Hanna, Z., Kay, D.G., Cool, M., Jothy, S., Rebai, N., and Jolicoeur, P. (1998). Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J. Virol. 72, 121-132.
13. Harris, M. (1996). From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef. J. Gen. Virol. 77, 2379-2392.
14. Herskowitz, A. (1996). Cardiomyopathy and othersymptomatic heart diseases associated with HIV infection. Curr. Opin. Cardiol. 11, 325-331.
15. Ho, D.D. (1996). Viral counts count in HIV infection. Science 272, 1124-1125.
16. Huang, M., Simard, C., Kay, D.G., and Jolicoeur, P. (1991). The majority of cells infected with the defective murine AIDS virus belong to the B cell lineage. J. Virol. 65, 6562-6571.
17. Iafrate, A.J., Bronson, S., and Skowronski, J. (1997). Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16, 673-684.
18. Kestler, H.W., Ringler, D.J., Mori, K., Panicali, D.L., Sehgal, P.K., Daniel, M.D., and Desrosiers, R.C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
19. Kirchhoff, F., Greenough, T.C., Brettler, D.B., Sullivan, J.L., and Desrosiers, B.C. (1995). Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Eng. J. Med. 332, 228-232.
20. Klotman, P.E., Bappaport, J., Bay, P., Kopp, J.B., Franks, B., Bruggeman, L.A., and Notkins, A.L. (1995). Transgenic models of HIV-1. AIDS 9, 313-324.
21. Kroemer, G. (1995). The pharmacology of T cell apoptosis. Adv. Immunol. 58, 211-296.
22. Levy, D.N., Fernandes, L.S., Williams, W.V., and Weiner, D.B. (1993). Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72, 541-550.
23. Li, C.J., Friedman, D.J., Wang, C., Metelev, V., and Pardee, A.B. (1995). Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268, 429-431.
24. Lindemann, D., Wilhelm, R., Benard, P., Althage, A., Zinkernagel, R., and Mous, J. (1994). Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. J. Exp. Med. 179, 797-807.
25. McSherry, G.D. (1996). Human immunodeficiency-virus-related pulmonary infections in children. Semin. Bespir. Infect. 11, 173-183.
26. Miller, M.D., Warmerdam, M.T., Gaston, I., Greene, W.C., and Feinberg, M.B. (1994). The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113.
27. Pantaleo, G., and Fauci, A.S. (1995). New concepts in the immunopathogenesis of HIV infection. Annu. Bev. Immunol. 13, 487-512.
28. Price, R.W. (1996). Neurological complications of HIV infection. Lancet 348, 445-452.
29. Rogel, M.E., Wu, L.I., and Emerman, M. (1995). The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69, 882-888.
30. Seney, F.D., Jr., Burns, D.K., and Silva, F.G. (1990). Acquired immunodeficiency syndrome and the kidney. Am. J. Kidney. Dis. 16, 1-13.
31. Siliciano, R.F. (1996). The role of CD4 in HIV envelope-mediated pathogenesis. Curr. Top. in Microbiol. Immunol. 205, 159-179.
32. Skowronski, J., Parks, D., and Mariani, R. (1993). Altered T cell activation and development in transgenic m ice expressing the HIV-1 nef gene. EMBO J. 12, 703-713.
33. Viscidi, R.P., Mayur, K., Lederman, H.M., and Frankel, A.D. (1989). Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246, 1606-1608.
34. Weiss, A., and Littman, D.R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
35. Willey, R.L., Maldarelli, F., Martin, M.A., and Strebel, K. (1992). Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-7200.
36. Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R.P., and Samelson, L.E. (1998). LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92, 83-92.